We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M Turnover 22.11%
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+18%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$189M
AUM Growth
+$21.1M
Cap. Flow
-$3.54M
Cap. Flow %
-1.87%
Top 10 Hldgs %
62.82%
Holding
95
New
10
Increased
16
Reduced
4
Closed
11
Avg Time Held
2.3 years
Top 10 Avg Time Held
1.4 years
Top 20 Avg Time Held
1.2 years

Top Buys

Rank Stock Value
1
CLST icon
Catalyst Bancorp
CLST
+$1.84M
2
SPRB icon
Spruce Biosciences
SPRB
+$1.12M
3
CGEM icon
Cullinan Oncology
CGEM
+$668K
4
INSM icon
Insmed
INSM
+$515K
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$512K

Top Sells

Rank Stock Value
1
CPRX icon
Catalyst Pharmaceutical
CPRX
+$2.97M
2
ACLX icon
Arcellx
ACLX
+$2.23M
3
CYTK icon
Cytokinetics
CYTK
+$1.56M
4
CNTA
Centessa Pharmaceuticals
CNTA
+$1.55M
5
TGTX icon
TG Therapeutics
TGTX
+$948K

Sector Composition

Rank Sector Weight
1 Healthcare 52.57%
2 Financials 20.08%
3 Communication Services 17.13%
4 Miscellaneous 7.75%
5 Technology 1.3%

No holdings matched the selected filter criteria.

1 2 3 4

Similar funds

SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM
SHC
SALT Holding Corp Wilmington, Delaware $189M AUM 34.63% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $190M AUM 42.56% 1-Year Est. Return

David M. Knott Jr's Q2 2026 Portfolio in Review

As of Q2 2026, David M. Knott Jr held 95 positions worth $189M, up 13% from $168M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

David M. Knott Jr's Q2 2026 filing shows 10 new, 16 increased, 4 reduced and 11 closed positions. Its largest new stake was Catalyst Bancorp: 114,000 shares worth $3.58M. The largest sale was Catalyst Pharmaceutical, an estimated $2.97M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Financials and Communication Services.

  • David M. Knott Jr's largest Q2 2026 buy was Catalyst Bancorp: 114,000 shares worth $3.58M.
  • David M. Knott Jr added most to Cullinan Oncology in Q2 2026, an estimated $668K increase.
  • David M. Knott Jr's biggest Q2 2026 reduction was TG Therapeutics, cutting an estimated $948K.
  • David M. Knott Jr fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $2.97M.
  • David M. Knott Jr's ten largest holdings make up 63% of its $189M portfolio in Q2 2026.
  • David M. Knott Jr opened 10 new positions and closed 11 in Q2 2026.
  • David M. Knott Jr's portfolio value rose 13% quarter-over-quarter to $189M.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.